文献速递胸部肿瘤

生殖系BAP1突变携带者中发生的间皮瘤的临床与病理表型分析

Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations.
PubMed 文献 · J Thorac Oncol · 2025-06-27

研究1999至2024年47个携带生殖系BAP1杂合失活突变的家族,238名BAP1+/-携带者中84例(35%)诊断间皮瘤,仅1例有石棉暴露证据,未遗传突变的123名亲属中无间皮瘤(p<0.0001)。BAP1+/-间皮瘤患者发病年龄较轻,45.2%发生多原发癌,肿瘤呈惰性、多腔隙扁平病变,早期不需积极治疗,但深部实性浸润者生存差。

要点

  • 238名BAP1+/-携带者中84例(35%)诊断间皮瘤,仅1例有石棉暴露证据。
  • 未遗传BAP1+/-的123名亲属中无间皮瘤发生(p<0.0001)。
  • BAP1+/-间皮瘤呈惰性、多腔隙1至3 mm扁平白斑,影像常阴性,早期不需积极治疗。

核心结论

  • 与散发性间皮瘤相比,BAP1+/-携带者发生的间皮瘤在生物学、组织学和临床上是一种不同的疾病,这些患者需要量身定制的临床方法。

研究设计与样本

  • 1999年至2024年研究47个以孟德尔方式传递BAP1+/-的家族,对突变进行特征分析、收集家族史和临床记录、绘制家系图并诊断间皮瘤。

主要发现

  • 鉴定出34种不同的生殖系失活突变,238名27至81岁BAP1+/-携带者中84例(35%)诊断间皮瘤,84例中仅1例有石棉暴露证据。
  • 未遗传BAP1+/-的123名兄弟姐妹或一、二级亲属中无间皮瘤记录(p<0.0001)。
  • 84例BAP1+/-患者发病年龄相对较轻,45.2%发生多原发癌。
  • 胸腔镜和腹腔镜显示多腔隙约1至3 mm白色扁平病变,但影像学通常无癌症证据;组织学显示缺乏BAP1核染色的上皮样细胞呈管状乳头状和梁状结构,局灶侵犯间皮下脂肪组织,可能被诊断为IV期转移性间皮瘤。
  • 这些肿瘤多年保持惰性,早期阶段患者不需要积极治疗;约1/3患者出现影像可见病变,手术、化疗或两者联合使生存达数年,部分治愈;间皮瘤细胞深部浸润伴实性结构罕见,这些病例生存差。

关键数值与推荐

  • 作者将这类肿瘤称为「低级别生殖系突变BAP1相关间皮瘤(L-BAM)」,以区别于侵袭性、治疗抵抗的散发性间皮瘤。

临床怎么用

  • 作者认为BAP1+/-携带者发生的间皮瘤需要量身定制的临床方法;早期惰性阶段患者不需要积极治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Mesothelioma is frequent among carriers of inactivating heterozygous germline BAP1 mutations (BAP1+/-). We studied whether the natural history and the pathology of mesotheliomas in BAP1+/- carriers differed from sporadic, not genetically related, mesotheliomas. METHODS: During 1999 to 2024, we studied 47 families carrying BAP1+/- transmitted in a Mendelian fashion. We characterized these mutations, collected family history, clinical records, prepared family pedigrees, and diagnosed their mesotheliomas. RESULTS: We identified 34 different germline inactivating mutations. Among 238 BAP1+/- carriers aged 27 to 81 years, 84 were diagnosed with mesothelioma (35%) and one of 84 had evidence of asbestos exposure. No mesothelioma was recorded among 123 siblings, first- or second-degree relatives who did not inherit BAP1+/- (p < 0.0001). The 84 patients with BAP1+/- developed mesothelioma at a relatively young age; 45.2% developed multiple cancers. Patients with BAP1+/- had a florid, diffuse mesothelial hyperplasia often present in both pleural cavities, peritoneum and pericardium. Thoracoscopy and laparoscopy results revealed several multicavity approximately 1 to 3 mm whitish flat lesions, but imaging result was usually negative for cancer. Histology results revealed epithelioid cells lacking BAP1 nuclear staining arranged in tubulopapillary and trabecular architectures, focally invading submesothelial adipose tissue. These findings may lead to the diagnosis of stage IV metastatic mesothelioma. However, we found that these tumors remain indolent for years, and, at this early stage, patients do not require aggressive therapy. We refer to these tumors as "low-grade-germline-mutant-BAP1-associated-mesotheliomas, L-BAM" to distinguish them from aggressive, therapy-resistant, sporadic mesotheliomas. For the 1/3 of patients who developed lesions visible by imaging, surgery, chemotherapy, or a combination of both led to survival of several years, and some were cured. Deep invasion by mesothelioma cells with a solid architecture is rare: these cases have poor survival. CONCLUSIONS: Compared with sporadic mesotheliomas, mesotheliomas developing in BAP1+/- carriers are a different disease, biologically, histologically, and clinically; these patients require a tailored clinical approach.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Carbone M, Minaai M, Kittaneh M, et al. Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations. J Thorac Oncol. 2025. PMID: 40582407. doi:10.1016/j.jtho.2025.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。